Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Pfizer presents new series of JAK3 inhibitors for autoimmune diseases

Jan. 24, 2000

SmithKline Beecham signs CpG DNA immune stimulant agreement

Jan. 21, 2000

North American Vaccine to seek NeisVac-C approval in U.K. shortly

Jan. 20, 2000

QS-21 license granted to Elan

Jan. 20, 2000

Avant's cholera vaccine to enter phase IIb trial

Jan. 19, 2000

Isolation of unnamed tick-borne bacterium causing HGE patented by Aquila

Jan. 17, 2000

FDA accepts NDA for new Rapamune formulation

Jan. 14, 2000

KF-20444 has potent immunosuppressive activity

Jan. 14, 2000

Licensing opportunity from NIH: live attenuated RSV and PIV for use as human vaccines

Jan. 10, 2000

Medarex antibody therapy reduces inflammation in vivo

Jan. 6, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...